Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2 in the revision history.
    Difference
    0.1%
    Check dated 2026-03-11T16:39:40.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Results section updated with data on dose-limiting toxicities, timing, and RECIST responses. Exploratory biomarker endpoints were removed.
    Difference
    3%
    Check dated 2026-02-18T04:24:21.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1 along with the funding/operating-status notice. There are no visible changes to the study details or results.
    Difference
    0.5%
    Check dated 2026-02-11T02:32:19.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Administrative notices were added: a government funding lapse notice and an update to version 3.4.1. The prior version 3.4.0 was removed.
    Difference
    0.5%
    Check dated 2026-02-03T23:25:13.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated footer/version details to show 'Last Update Submitted that Met QC Criteria' and Revision: v3.4.0. Removed older wording/capitalization variants ('Last Update Submitted that met QC Criteria', 'No FEAR Act data') and the previous revision label (v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T00:17:16.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous Revision: v3.3.3 on the page header/footer. This appears to be a minor system update and does not affect trial details.
    Difference
    0.1%
    Check dated 2026-01-13T17:43:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.